Effective B cell activation in vitro during viremic HIV-1 infection with surrogate T cell stimulation

Immunobiology
Lindsay K NicholsonE N Janoff

Abstract

Identifying HIV-1-associated B cell defects and responses to activation may direct interventions to circumvent their impaired antibody responses to infection and vaccines. Among 34 viremic HIV-1-infected and 20 seronegative control adults, we measured baseline frequencies and activation of B and T cell subsets, expression of activation-induced cytidine deaminase (AID), potential determinants of B cell activation in vivo and B and T cell responses in vitro. At baseline, HIV-1 infection was associated with increased IgM memory and decreased anergic cell frequencies, as well as increased activation in all 10 B cell subsets compared with controls. HIV-1 status, TFH activation, and BAFF were significant potential drivers of B cell activation. Despite high baseline activation among HIV-1-infected subjects, stimulation in vitro with combined surrogates for antigen (anti-IgM), cognate (CD40 ligand) and soluble T cell factors (IL-4) elicited comparable B cell activation, transitions from naïve to class-switched memory cells and AID expression in both groups. In summary, viremic HIV-1 infection perturbs circulating B cell subsets and activation at each stage of B cell maturation. However, that appropriate stimulation of B cells elicits e...Continue Reading

References

Aug 15, 1998·Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association·Z LiuJ V Giorgi
Jun 3, 2000·Annual Review of Immunology·D T Fearon, M C Carroll
Aug 16, 2001·Proceedings of the National Academy of Sciences of the United States of America·S MoirA S Fauci
Apr 12, 2003·The Journal of Experimental Medicine·Stephanie KruetzmannRita Carsetti
Jun 10, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Angela MalaspinaAnthony S Fauci
Feb 24, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Brent E PalmerCara C Wilson
Mar 21, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Bing HeAndrea Cerutti
Dec 13, 2006·Proceedings of the National Academy of Sciences of the United States of America·Jason HoAnthony S Fauci
Jun 6, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Melanie HartPeter Kelleher
Jun 13, 2008·The Journal of Allergy and Clinical Immunology·Susan Moir, Anthony S Fauci
Mar 24, 2009·Annual Review of Immunology·Jean-Claude WeillClaude-Agnès Reynaud
Mar 5, 2010·The New England Journal of Medicine·Neil FrenchCharles F Gilks
Apr 26, 2011·Gut·Anna HaasUNKNOWN Swiss HIV Cohort Study
May 3, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Suresh PallikkuthSavita Pahwa
Jul 5, 2011·Cellular Immunology·Rachelle M BuchananHeather L Wilson
Jul 26, 2011·Nature Medicine·Michelle A LintermanCarola G Vinuesa
Aug 3, 2012·Human Vaccines & Immunotherapeutics·Rasmus OffersenOle S Søgaard
Aug 28, 2012·The Journal of Clinical Investigation·Madelene LindqvistHendrik Streeck
Dec 18, 2012·Nature Immunology·Peter T SageArlene H Sharpe
Mar 12, 2013·Nature Medicine·Rafael A CubasElias K Haddad
Apr 19, 2013·AIDS·Sylvie AmuFrancesca Chiodi
Jun 15, 2013·AIDS Research and Human Retroviruses·Basile SieweAlan Landay
Feb 6, 2014·PLoS Pathogens·Kristin L BoswellRichard A Koup
Apr 16, 2014·The Journal of Experimental Medicine·Marc DescatoireClaude-Agnès Reynaud
Apr 22, 2014·Autoimmunity Reviews·Laura IordacheUNKNOWN Associated authors
Jun 4, 2014·The Journal of Clinical Investigation·Lela KardavaAnthony S Fauci

❮ Previous
Next ❯

Citations

May 2, 2021·The Journal of Immunology : Official Journal of the American Association of Immunologists·Vibha JhaEdward N Janoff

❮ Previous
Next ❯

Related Concepts

Related Feeds

B cell Activation

B cell activation is initiated by the ligation of the B cell receptor with antigen and ultimately results in the production of protective antibodies against potentially pathogenic invaders. Here is the latest research.